PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
October 26, 2023The Lancet Regional Health - Europe31 citationsOpen Access

Vaccine effectiveness against hospitalisation estimated using a test-negative case-control study design, and comparative odds of hospital admission and severe outcomes with COVID-19 sub-lineages BQ.1, CH.1.1. and XBB.1.5 in England

FKFreja KirsebomKHKatie HarmanRLRachel Lunt

Key Points

Key points are not available for this paper at this time.

Abstract

None.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Kirsebom et al. (2023) studied this question.

synapsesocial.com/papers/69dabecd7a67537a8ba3c4e3https://doi.org/10.1016/j.lanepe.2023.100755
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England2022 · 176 citations
  2. 2Healthcare-associated COVID-19 in England: A national data linkage study2021 · 106 citations
  3. 3Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines2022 · 683 citations
  4. 4Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1 and XBB.1 by parental mRNA vaccine or a BA.5 bivalent booster2022 · 451 citations